Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Indicio is a private public-benefit software company that provides digital identity, biometric authentication, and verifiable credential infrastructure under its flagship Indicio Proven platform. The company is not a drug developer or traditional biotech/pharma company; instead, it sells trust and identity orchestration technology used across sectors including healthcare, financial services, travel, government, and enterprise workflows. In healthcare, Indicio positions its technology to support secure sharing of patient and professional credentials, privacy-preserving health data exchange, and streamlined onboarding and verification. The company also offers document verification, wallet, SDK, API, and network capabilities designed for interoperable decentralized identity deployments. Its business is commercial-stage and centered on enterprise software deployments rather than therapeutic R&D.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Indicio.